Published in Fertil Steril on June 01, 2001
Virtual Reality Use in Assisted Reproductive Technology | NCT04394962
Increased MMPs expression and decreased contraction in the rat myometrium during pregnancy and in response to prolonged stretch and sex hormones. Am J Physiol Endocrinol Metab (2012) 0.84
Effects of vaginal progesterone administration starting on the day of oocyte retrieval on pregnancy rates. J Assist Reprod Genet (2003) 0.83
EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone. Biochem Pharmacol (2013) 0.81
Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue? J Ovarian Res (2015) 0.80
Administration of beta2-adrenergic agonists during the peri-implantation period does not improve implantation or pregnancy rates in intracytoplasmic sperm injection (ICSI) cycles. J Assist Reprod Genet (2003) 0.77
Efficacy of oxytocin antagonist infusion in improving in vitro fertilization outcomes on the day of embryo transfer: A meta-analysis. Clin Exp Reprod Med (2016) 0.75
Assessment of the luteal phase in stimulated and substituted cycles. Facts Views Vis Obgyn (2009) 0.75
Timing luteal support in assisted reproductive technology: a systematic review. Fertil Steril (2015) 0.75
Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia. Prog Mol Biol Transl Sci (2017) 0.75
[Home birth: opinion of French women and perinatal risk. Results of the French overseas departments 2000 survey]. Gynecol Obstet Fertil (2002) 3.28
Antenatal thrombocytopenia in three patients with TAR (thrombocytopenia with absent radii) syndrome. Prenat Diagn (1993) 2.11
[Should one demonize IVF?]. Gynecol Obstet Fertil (2003) 2.03
Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis. J Med Genet (2005) 2.00
Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention. Fertil Steril (1990) 1.81
Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod (1998) 1.80
A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma. J Clin Endocrinol Metab (1998) 1.72
Fertility and pregnancy outcomes following hypogastric artery ligation for severe post-partum haemorrhage. Hum Reprod (2003) 1.64
High pregnancy rate after early human embryo freezing. Fertil Steril (1986) 1.62
Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb Haemost (2001) 1.60
Vaginal mesh erosion after transvaginal repair of cystocele using Gynemesh or Gynemesh-Soft in 138 women: a comparative study. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.58
Management in intractable obstetric haemorrhage: an audit study on 61 cases. Eur J Obstet Gynecol Reprod Biol (2001) 1.49
Mild ovarian stimulation for IVF. Hum Reprod Update (2008) 1.48
[Increased nuchal translucency with normal karyotype]. Gynecol Obstet Fertil (2007) 1.44
Time relationships between basal body temperature and ovulation or plasma progestins. Fertil Steril (1984) 1.43
[Use of aromatase inhibitors in infertile women]. Gynecol Obstet Fertil (2005) 1.43
Treatment of unruptured tubal pregnancy with methotrexate: pharmacokinetic analysis of local versus intramuscular administration. Fertil Steril (1994) 1.42
Transabdominal fetoscopy in fetal anomalies diagnosed by ultrasound in the first trimester of pregnancy. Ultrasound Obstet Gynecol (1996) 1.42
[Maternofetal disseminated candidiasis and high-grade prematurity]. Arch Pediatr (1997) 1.42
Minimum time lapse between luteinizing hormone surge or human chorionic gonadotropin administration and follicular rupture. Fertil Steril (1982) 1.41
Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab (2002) 1.41
Different implantation rates after transfers of cryopreserved embryos originating from donated oocytes or from regular in vitro fertilization. Fertil Steril (1990) 1.41
A new system for fallopian tube sperm perfusion leads to pregnancy rates twice as high as standard intrauterine insemination. Fertil Steril (1995) 1.40
Uterine contractility decreases at the time of blastocyst transfers. Hum Reprod (2001) 1.38
[Alternatives to amniocentesis for maternal age]. Gynecol Obstet Fertil (2002) 1.38
Development of a training model for ultrasound-guided invasive procedures in fetal medicine. Ultrasound Obstet Gynecol (1995) 1.36
Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril (2000) 1.35
Nonsurgical treatment of heterotopic pregnancy: a report of six cases. Fertil Steril (1993) 1.33
Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study. Hum Reprod (1995) 1.26
Pre-hCG elevation of plasma progesterone: good, bad or otherwise. Hum Reprod Update (2008) 1.22
A 2-year study on cytomegalovirus infection during pregnancy in a French hospital. BJOG (2009) 1.20
Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab (1988) 1.16
Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod (2002) 1.16
Direct transport of progesterone from vagina to uterus. Obstet Gynecol (2000) 1.16
The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod (2007) 1.15
In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience. Hum Reprod (2004) 1.14
Successful management of a heterotopic Caesarean scar pregnancy: potassium chloride injection with preservation of the intrauterine gestation: case report. Hum Reprod (2003) 1.13
The use of GnRH antagonists in ovarian stimulation. Hum Reprod Update (2002) 1.11
Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Hum Reprod (2002) 1.11
The increased risk of complication observed in singleton pregnancies resulting from in-vitro fertilization (IVF) does not seem to be related to the IVF method itself. Hum Reprod (1993) 1.11
Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy. Fertil Steril (1997) 1.11
Expression of Na+/I- symporter and Pendred syndrome genes in trophoblast cells. J Clin Endocrinol Metab (2000) 1.10
Stability of the m.8993T->G mtDNA mutation load during human embryofetal development has implications for the feasibility of prenatal diagnosis in NARP syndrome. J Med Genet (2007) 1.10
Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in-vitro fertilization. Hum Reprod (1994) 1.10
A protocol using a low dose of gonadotrophin-releasing hormone agonist might be the best protocol for patients with high follicle-stimulating hormone concentrations on day 3. Hum Reprod (1996) 1.09
Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. Hum Reprod (2005) 1.07
The efficacy of "tubal sperm perfusion"? Fertil Steril (1996) 1.07
Comment on the debate article: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod (2001) 1.07
Four indications for embryo transfer at the blastocyst stage. Hum Reprod (1994) 1.07
Perinatal outcome and developmental studies on children born after IVF. Hum Reprod Update (2002) 1.07
Laparoscopically assisted vaginal hysterectomy. Lancet (1992) 1.06
Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril (1993) 1.06
Uterine contractility during the menstrual cycle. Hum Reprod (2000) 1.06
Effect of mono-(2-ethylhexyl) phthalate on human and mouse fetal testis: In vitro and in vivo approaches. Toxicol Appl Pharmacol (2012) 1.05
Chorionic villus sampling after first trimester diagnosis of fetal cystic hygroma colli. Eur J Obstet Gynecol Reprod Biol (1989) 1.04
Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus. Hum Reprod Update (1999) 1.02
Vaginal misoprostol for cervical ripening before operative hysteroscopy in pre-menopausal women: a double-blind, placebo-controlled trial with three dose regimens. Hum Reprod (2004) 1.02
[Vaginal mesh extrusion after transvaginal repair of cystocele using a prosthetic mesh: Treatment and functional outcomes]. J Gynecol Obstet Biol Reprod (Paris) (2006) 1.02
Fertility and pregnancy outcome following pelvic arterial embolization for severe post-partum haemorrhage. A cohort study. Hum Reprod (2003) 1.02
Targeted drug delivery in gynaecology: the first uterine pass effect. Hum Reprod (1997) 1.01
Ultrasound study of the endometrium during in vitro fertilization cycles. Fertil Steril (1985) 1.01
Physiological studies of human chorionic gonadotropin (hCG), alpha hCG, and beta hCG as measured by specific monoclonal immunoradiometric assays. Endocrinology (1987) 1.00
Factors influencing the success rate of human embryo freezing in an in vitro fertilization and embryo transfer program. Fertil Steril (1987) 1.00
Interpretation of plasma luteinizing hormone assay for the collection of mature oocytes from women: definition of a luteinizing hormone surge-initiating rise. Fertil Steril (1981) 0.99
[Congenital toxoplasmosis: transmission to the fetus of a pre-pregnancy maternal infection]. Presse Med (1995) 0.99
Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins. J Clin Endocrinol Metab (1992) 0.98
Effect of dexamethasone and betamethasone on fetal heart rate variability in preterm labour: a randomised study. Br J Obstet Gynaecol (1998) 0.98
Amniotic fluid concentrations of interleukin-1beta, interleukin-6 and TNF-alpha in chorioamnionitis before 32 weeks of gestation: histological associations and neonatal outcome. Br J Obstet Gynaecol (1999) 0.98
Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation. Fertil Steril (1988) 0.98
[The follicular flushing duplicate the pregnancy rate on semi natural cycle IVF]. J Gynecol Obstet Biol Reprod (Paris) (2007) 0.97
Transvaginal administration of progesterone. Obstet Gynecol (1997) 0.96
Meiosis initiation in the human ovary requires intrinsic retinoic acid synthesis. Hum Reprod (2010) 0.96
The A.R.T. of embroidery. Hum Reprod (1996) 0.96
Essure sterilization associated with endometrial ablation. Int J Gynaecol Obstet (2007) 0.96
Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial. Hum Reprod (1993) 0.96
Alternative to surgery of treatment of unruptured interstitial pregnancy: 15 cases of medical treatment. Eur J Obstet Gynecol Reprod Biol (1996) 0.96
New look at endometrial echogenicity: objective computer-assisted measurements predict endometrial receptivity in in vitro fertilization-embryo transfer. Fertil Steril (2000) 0.95